New combo aims to boost esophageal cancer treatment before surgery
NCT ID NCT06078709
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with stage I to III esophageal or gastroesophageal junction cancer. It tests whether giving a shorter, higher-dose radiation treatment along with chemotherapy (FOLFOX) before surgery can kill more cancer cells. The goal is to see if this approach leads to a complete response in the tumor. About 99 adults will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL STAGE I ESOPHAGEAL ADENOCARCINOMA AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic in Arizona
NOT_YET_RECRUITINGScottsdale, Arizona, 85259, United States
Contact Email: •••••@•••••
-
Mayo Clinic in Florida
ACTIVE_NOT_RECRUITINGJacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug combo targets Hard-to-Treat GI cancers
- New drug cocktail aims to fight Hard-to-Treat stomach cancers
- Experimental combo targets Hard-to-Treat esophageal cancer
- Heart monitor reveals hidden damage from cancer radiation
- New study tracks physical decline during cancer treatment
- New drug cocktail targets Hard-to-Treat stomach cancer